Noticed that too... also since I started getting o
Post# of 148168
Maybe the contract with RedChip has ended and instead of paying an investor/public relations company, CytoDyn is opting to do their own investor/press releases and also do the calls themselves... regarding the two calls so far by the company that I've been on, Dr. Pourhassan spearheaded or hosted the call.
On another note, I believe on a number of calls, Dr. Pourhassan brought up Dr. Kelly regarding a few important matters:
Kelly apparently brought in Dr. Bruce Patterson
Kelly apparently brought back Dr. Nitya Ray
Kelly apparently kept Pourhassan in the game, helping him in challenging times (also willing to excercise his warrants in May)
Kelly apparently has a lot to do with getting manufacturing
Kelly apparently has Pourhassan's ear and full attention
Wondering if they've now hired the "Commercial Officer" and set up their "powerful Science Advisory Board" for NASH, HIV and cancer which Dr. Kelly was supposed to be forming...
About Dr. Scott Kelly:
April 2017: Director
Dec. 2018: Chairman of the Board
July 2019: Chief Science Officer
April 2020: Chief Medical Officer and Head of Business Development